Molecular Oncology is an Open Access international journal that highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational cancer research.
The emphasis is on work that significantly advances our understanding of disease processes leading to human tumour development and/or establishes novel concepts of clear clinical significance in diagnosis, prognosis and prevention strategies for cancer patients.
Topics include, but are not limited to:
- Key biological processes such as cell cycle; DNA repair; apoptosis; invasion and metastasis; angiogenesis and lymphangiogenesis; cell signalling and interactive networks; immune response.
- Emerging technologies (genomics, proteomics, functional genomics, metabolomics, tissue arrays, imaging), and model systems.
- Biomarkers: diagnosis, prognosis, stratification and efficacy.
- Cancer genetics, epigenetics, and genomic instability.
- Minimal residual disease, pre-malignant lesions.
- Cancer micro-environment.
- Molecular pathology.
- Tumour immunology.
- Translational research.
- Cancer therapy (target discovery, drug design, immunotherapy, combination therapies, resistance, and individualised treatment).
- Chemotherapy, radiotherapy and surgery.
- Clinical pharmacology.
- Clinical trials, integration of basic science into cancer clinical trials.
- Molecular epidemiology.
Product Type: Journal
Author/Editor: Celis, Julio E.
Update Frequency: Monthly
Coverage: Vol 1 #1 (2007) - Present
Pdf Coverage: Vol 1 #1 (2007) - Present
Impact Factor: 5.314